Live For medical affairs, competitive intelligence and market access

Pharma answers your agent can cite.
Trials, labels, exclusivity and coverage behind one URL.

Ask when a patent expires, which biosimilars are approved, what a label warns about, or what Medicare decided — and get the answer with the record it came from. Your agent reads ClinicalTrials.gov, the FDA, CMS and PubMed directly, so nothing rests on what a model happened to memorise during training, and nothing has to be scraped.

One URL · no per-source API keys · free to start

What it answers

Grouped by the job, not by the database. Every question shown below was run against the live gateway before it was printed here.

Competitive intelligence, BD, forecasting

Loss of exclusivity and generic entry

“When do the patents on Eliquis expire?”

All 25 Orange Book patents with expiry dates, drug-substance and drug-product flags, and use codes.

  • Which biosimilars are approved for Humira? — Purple Book, with BLA numbers and interchangeability status
  • Exclusivity expirations and competition profiles by application
Medical affairs, clinical development

Pipeline and trial landscape

“What phase 3 clinical trials are recruiting for Alzheimer’s disease?”

ClinicalTrials.gov, filtered by phase, status, sponsor, condition and location.

  • Every trial a given sponsor is running, and how a condition’s trial count is trending
  • Study records by NCT number, with recent protocol updates
Pharmacovigilance, regulatory affairs

Safety, labels and supply

“What are the warnings on the FDA label for lisinopril?”

The current FDA label section, quoted, with the label it came from.

  • Which drugs are currently in shortage in the US? — live FDA shortage list and status changes
  • FAERS adverse-event counts, recalls, warning letters, and Complete Response Letters
Market access, pricing, HEOR

Coverage and reimbursement

  • Medicare national and local coverage determinations, with the policy timeline behind a decision
  • Part D spending by drug, prescriber exposure, and generic-competition pressure
  • Medicaid drug utilisation by state, and managed-care market mix
  • CMS Open Payments — what a manufacturer paid which physicians, and for what

A real answer, with its receipt

“When do the patents on Eliquis expire?”

orange_book_patent_expirations · FDA Orange Book
{
  "returned": 25,
  "patents": [
    {
      "patent_number": "6967208",
      "expiration_date": "2026-11-21",
      "drug_substance": true,
      "drug_product": true,
      "use_code": "U-1501"
    },
    ...
  ]
}

Run live on 2026-08-11. The agent gets the patent numbers and dates, not a sentence about them — so it can compute a loss-of-exclusivity date and show you which filing said so.

Where the answers come from

Primary sources only. No scraped aggregators, and no model-written summary standing in for a record.

Regulatory

FDA drug and novel approvals, labels, recalls, shortages, warning letters, Complete Response Letters, FAERS adverse events, and the device side (510(k), PMA, UDI).

Exclusivity

Orange Book patents and exclusivity expirations with competition profiles; Purple Book biosimilars, interchangeables and reference products.

Clinical

ClinicalTrials.gov — search, study records, sponsor portfolios, counts by condition, recent updates and trials by location.

Reimbursement

Medicare national and local coverage determinations and their timelines, Part D spending and prescriber exposure, Medicaid utilisation by state, CMS Open Payments.

Evidence

PubMed and Europe PMC — search, abstracts, citations, related articles, and full text where it is open.

The public-company side

SEC filings, XBRL fundamentals, insider transactions and 8-K catalysts for listed sponsors.

Connect it in about a minute

One URL, scoped so your agent sees these 258 tools rather than the whole catalogue. Works in Claude, ChatGPT, Cursor, Gemini and anything else that speaks MCP.

gateway URL
https://gateway.pipeworx.io/mcp?vertical=pharma

Free to start — no card, no API keys. Paid usage is credits, priced per call; see pricing.

Common questions

What data sources are included in PharmaPulse?

ClinicalTrials.gov (active and completed trials by phase, sponsor, condition), OpenFDA (adverse events, drug approvals, label data), RxNorm (drug normalization, ingredient mapping), DailyMed (structured labels), SEC EDGAR (pharma company filings), and USPTO (patents and trademarks). Covers competitive intelligence, safety analysis, and clinical pipeline tracking.

Can I get a complete safety profile for a drug from one call?

Yes — the drug_safety_profile prompt and the pharma_drug_profile _intel tool fan out across RxNorm, OpenFDA adverse events, ClinicalTrials, and DailyMed in parallel. A query like "What are the side effects of Ozempic?" returns adverse event counts (54k+ reports for semaglutide), interaction warnings, and label sections in one round trip.

How do I track Phase 3 trials or competitive pipelines for a condition?

ClinicalTrials.gov tools let an agent filter trials by phase, status (recruiting, active, completed), condition, sponsor, and intervention type. Combine with EDGAR filings on the sponsor companies and USPTO patent search on the molecule for a full competitive-intelligence brief.

Is the drug data live or cached?

ClinicalTrials.gov updates are typically reflected within hours. OpenFDA adverse events are refreshed quarterly by FDA, with the most recent quarter usually 2–3 months behind. RxNorm releases monthly. Every response includes _meta.cache.fresh_until so agents can decide whether to refetch.